Debt-to-equity of RxSight, Inc. from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
RxSight, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2022 to 30 Sep 2025.
  • RxSight, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 12%, a 0.92% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

RxSight, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 12% 0% +0.92% 30 Sep 2025
Q2 2025 12% 0% +0.16% 30 Jun 2025
Q1 2025 12% -3% -22% 31 Mar 2025
Q4 2024 12% -10% -46% 31 Dec 2024
Q3 2024 12% -20% -62% 30 Sep 2024
Q2 2024 12% -32% -73% 30 Jun 2024
Q1 2024 16% -38% -71% 31 Mar 2024
Q4 2023 22% -33% -60% 31 Dec 2023
Q3 2023 32% -16% -34% 30 Sep 2023
Q2 2023 44% +2% +5.9% 30 Jun 2023
Q1 2023 53% -165% -76% 31 Mar 2023
Q4 2022 55% 31 Dec 2022
Q3 2022 48% 30 Sep 2022
Q2 2022 42% 30 Jun 2022
Q1 2022 219% 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.